Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thrombo-inflammation Des Maladies Neurovascualires aiguës : définition de Nouvelles Cibles thérapeutiques (TARGETS)

NCT07354321 is registered in ClinicalTrials.gov with François Delvoye as lead sponsor.

NCT NCT07354321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07354321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thrombo-inflammation Des Maladies Neurovascualires aiguës : définition de Nouvelles Cibles thérapeutiques (TARGETS)
Lead sponsor
François Delvoye
Phase
Observational
Overall status
Not yet recruiting
Start date
February 28, 2026
Completion date
December 31, 2032
Enrollment
499 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

delayed cerebral ischemia after subarachnoid hemorrhage, ischemic stroke of large or medium vessels